Crossject Appoints Tony Tipton as U.S. Chief Operating Officer in Preparation for Commercialization of ZEPIZURE® Epilepsy Rescue Treatmentnews2024-08-19T18:44:33+00:00August 19th, 2024|Medical Device News Magazine|
